Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02682056 · ClinicalTrials.gov registry record · NA
Glucose Measurement Using Microneedle Patches
A NA study of Diabetes, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 2
- Study locations
NCT02682056: Completed NA study of Diabetes, sponsored by Emory University.
NCT02682056 is a NA study of Diabetes that has completed, run by Emory University. The registered enrollment target is 15 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02682056, a NA study of Diabetes, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will compare three glucose measurement techniques among diabetic children and adolescents. The study seeks to determine if a microneedle patch (made from biocompatible polymers or metal), versus a lancet or intravenous catheter, would be a preferable option for monitoring glucose levels among the diabetic pediatric population.
Primary Outcome
Participants had their glucose levels tested through three different methods. Interstitial glucose levels was assessed using a microneedles patch. Blood glucose levels were collected via the lancet and intravenous (IV) collection methods.
Conditions Studied
Interventions
- DEVICE Microneedle patch
- DEVICE Intravenous (IV) catheter
- DEVICE Lancet
Study Locations (2)
Georgia
- Children's Healthcare of Atlanta - Atlanta
- Emory Children's Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-12-21 |
| Est. Completion | 2018-01-29 |
| Phase | NA |
What the finished NCT02682056 record still lists
NCT02682056 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Microneedle patch is the first listed.
NCT02682056 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT02682056 about?
NCT02682056 is a clinical study titled "Glucose Measurement Using Microneedle Patches". This study will compare three glucose measurement techniques among diabetic children and adolescents. The study seeks to determine if a microneedle patch (made from biocompatible polymers or metal), versus a lancet or intravenous catheter, would be a preferable option for monitoring glucose levels a...
What is the current status of trial NCT02682056?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2017-12-21. Estimated completion is 2018-01-29.
What conditions does trial NCT02682056 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT02682056?
The interventions under investigation include: Microneedle patch (DEVICE), Intravenous (IV) catheter (DEVICE), Lancet (DEVICE).
Who is sponsoring clinical trial NCT02682056?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02682056 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02682056's enrollment target sits among peer trials
15 323rd of 338 higher than 15 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI